Angelman Syndrome Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Video
• Funding
• Clinical Trials

A Study of OV101 in Individuals With Angelman Syndrome (AS)
Condition:   Primary Disease or Condition Being Studied: Angelman Syndrome (AS) Interventions:   Drug: Gaboxadol;   Drug: Placebo Sponsor:   Ovid Therapeutics Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2019 Category: Research Source Type: clinical trials

A Phase 3 Study of OV101 in Pediatric Individuals With Angelman Syndrome (AS)
Condition:   Primary Disease or Condition Being Studied: Angelman Syndrome (AS) Intervention:   Drug: Gaboxadol Sponsor:   Ovid Therapeutics Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2019 Category: Research Source Type: clinical trials

A Study of OV101 in Individuals With Angelman Syndrome (AS)
Condition:   Primary Disease or Condition Being Studied: Angelman Syndrome (AS) Interventions:   Drug: Gaboxadol;   Drug: Placebo Sponsor:   Ovid Therapeutics Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2019 Category: Research Source Type: clinical trials

A Phase 3 Study of OV101 in Pediatric Individuals With Angelman Syndrome (AS)
Condition:   Primary Disease or Condition Being Studied: Angelman Syndrome (AS) Intervention:   Drug: Gaboxadol Sponsor:   Ovid Therapeutics Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2019 Category: Research Source Type: clinical trials

A Study of OV101 in Individuals With Angelman Syndrome (AS)
Condition:   Primary Disease or Condition Being Studied: Angelman Syndrome (AS) Interventions:   Drug: Gaboxadol;   Drug: Placebo Sponsor:   Ovid Therapeutics Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2019 Category: Research Source Type: clinical trials

A Phase 3 Study of OV101 in Pediatric Individuals With Angelman Syndrome (AS)
Condition:   Primary Disease or Condition Being Studied: Angelman Syndrome (AS) Intervention:   Drug: Gaboxadol Sponsor:   Ovid Therapeutics Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2019 Category: Research Source Type: clinical trials

Angelman Syndrome (AS) Biomarker Study
Conditions:   Angelman Syndrome;   Chromosome 15q Duplication (dup15q) Syndrome Interventions:   Procedure: Lumbar Puncture;   Procedure: Blood Collection Sponsor:   Biogen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2019 Category: Research Source Type: clinical trials